Cardiovascular disease risk assessment, exercise training, and management of complications in patients with chronic kidney disease.
| Title: | Cardiovascular disease risk assessment, exercise training, and management of complications in patients with chronic kidney disease. |
|---|---|
| Authors: | Perone F; Cardiac Rehabilitation Unit, Rehabilitation Clinic 'Villa delle Magnolie', Castel Morrone, 81020, Caserta, Italy.; Bernardi M; Department of Medical-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Latina, Italy.; Loguercio M; Cardiovascular Rehabilitation Unit, ASST Crema, Santa Marta Hospital, Rivolta D'Adda, Italy.; Jacoangeli F; Cardiologia riabilitativa e prevenzione patologie cardiovascolari, USL Umbria1, Perugia, Italy.; Velardi S; Division of Cardiology, University Magna Graecia, Catanzaro, Italy.; Metsovitis T; Catholic University of the Sacred Heart, Rome, Italy.; Ramondino F; S.C. di Medicina Interna, Azienda Socio Sanitaria Territoriale (ASST) della Brianza, Presidio Ospedaliero di Vimercate, Vimercate, Italy.; Ruzzolini M; Cardiology Department, Isola Tiberina-Gemelli Isola Hospital, Rome, Italy.; Ambrosetti M; Cardiovascular Rehabilitation Unit, ASST Crema, Santa Marta Hospital, Rivolta D'Adda, Italy. |
| Source: | International journal of cardiology. Cardiovascular risk and prevention [Int J Cardiol Cardiovasc Risk Prev] 2025 Mar 06; Vol. 25, pp. 200386. Date of Electronic Publication: 2025 Mar 06 (Print Publication: 2025). |
| Publication Type: | Journal Article; Review |
| Language: | English |
| Journal Info: | Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 9918282077306676 Publication Model: eCollection Cited Medium: Internet ISSN: 2772-4875 (Electronic) Linking ISSN: 27724875 NLM ISO Abbreviation: Int J Cardiol Cardiovasc Risk Prev Subsets: PubMed not MEDLINE |
| Imprint Name(s): | Original Publication: [Amsterdam] : Elsevier B.V., [2021]- |
| Abstract: | Patients with chronic kidney disease are at high and very high risk of cardiovascular disease. As estimated glomerular filtration rate declines, the incidence and severity of risk factors, complications, and atherosclerotic cardiovascular events increase. In this scenario, tailored assessment is the key to evaluate the severity of chronic kidney disease and estimate cardiovascular disease risk. Personalized stratification differentiates patients with chronic kidney disease without diabetes mellitus or established atherosclerotic cardiovascular disease in their management and beneficial treatment. Exercise intensity assessment and prescription is suggested to propose specific and safe recommendations for physical activity, training, and cardiac rehabilitation. Programs are based on a combination of endurance and resistance exercise and should be adapted to very high risk chronic kidney disease and haemodialysis patients and after kidney transplantation. Appropriate management of cardiovascular complications in these patients, such as risk factors, heart failure, arrhythmias, and coronary artery disease, is essential to ensure the best treatment and improve the prognosis. Therefore, we propose a critical and comprehensive review to suggest how to manage patients with chronic kidney disease in clinical practice and, specifically, with regard to cardiovascular risk assessment, exercise training prescription, and management of complications.; (© 2025 Published by Elsevier B.V.) |
| References: | Eur Heart J. 2021 Sep 7;42(34):3227-3337. (PMID: 34458905); J Am Coll Cardiol. 2003 May 7;41(9):1438-44. (PMID: 12742278); JACC Cardiovasc Imaging. 2014 Jul;7(7):715-28. (PMID: 25034921); Nat Rev Cardiol. 2009 Apr;6(4):301-11. (PMID: 19352334); Eur Heart J. 2024 Oct 7;45(38):3912-4018. (PMID: 39210715); Rev Assoc Med Bras (1992). 2020 Jan 13;66Suppl 1(Suppl 1):s03-s09. (PMID: 31939529); Sensors (Basel). 2023 Jan 26;23(3):. (PMID: 36772401); Int J Cardiol. 2016 Aug 15;217:16-27. (PMID: 27174593); Front Endocrinol (Lausanne). 2024 May 28;15:1390729. (PMID: 38863928); JAMA. 2015 Feb 24;313(8):837-46. (PMID: 25710660); Clin Res Cardiol. 2018 Mar;107(3):201-213. (PMID: 29101459); Chin Med J (Engl). 2018 Mar 05;131(5):608-614. (PMID: 29483398); Eur Heart J. 2023 Oct 14;44(39):4043-4140. (PMID: 37622663); PLoS One. 2021 Jul 1;16(7):e0251652. (PMID: 34197486); Int J Clin Pract. 2021 Nov;75(11):e14506. (PMID: 34117687); Eur Heart J. 2014 Feb;35(7):455-69. (PMID: 24164864); Kidney Med. 2019 May-Jun;1(3):131-138. (PMID: 32705080); J Am Heart Assoc. 2017 Oct 11;6(10):. (PMID: 29021274); Am Heart J. 2018 Nov;205:42-52. (PMID: 30172098); Kidney Int Rep. 2021 Mar 30;6(6):1537-1547. (PMID: 34169194); J Am Soc Nephrol. 2006 Jul;17(7):2034-47. (PMID: 16738019); Kidney Int Suppl (2011). 2022 Apr;12(1):7-11. (PMID: 35529086); Circ J. 2014;78(2):377-84. (PMID: 24225305); N Engl J Med. 2020 Oct 8;383(15):1436-1446. (PMID: 32970396); PLoS One. 2018 Sep 11;13(9):e0203662. (PMID: 30204785); PLoS One. 2018 Mar 21;13(3):e0192895. (PMID: 29561894); Clin J Am Soc Nephrol. 2010 Feb;5(2):173-81. (PMID: 20007681); Nefrologia (Engl Ed). 2019 Jan - Feb;39(1):29-34. (PMID: 30503082); J Am Soc Nephrol. 2017 Apr;28(4):1259-1268. (PMID: 27909047); Nephrol Dial Transplant. 2019 Nov 1;34(11):1803-1805. (PMID: 31566230); BMC Nephrol. 2022 Feb 22;23(1):75. (PMID: 35193515); Am Heart J. 2013 Sep;166(3):449-56. (PMID: 24016493); J Am Coll Cardiol. 2019 Oct 8;74(14):1823-1838. (PMID: 31582143); Heart Fail Rev. 2024 Mar;29(2):379-394. (PMID: 37728751); Eur J Prev Cardiol. 2024 Sep 6;31(12):1493-1515. (PMID: 38593202); Adv Exp Med Biol. 2019;1165:3-15. (PMID: 31399958); Expert Opin Pharmacother. 2023 Jun;24(8):935-945. (PMID: 37070470); Rev Cardiovasc Med. 2022 Nov 3;23(11):375. (PMID: 39076203); Circulation. 2018 Oct 9;138(15):1505-1514. (PMID: 30002098); Circ Res. 2023 Mar 3;132(5):652-670. (PMID: 36862812); Lancet. 2013 Jul 27;382(9889):339-52. (PMID: 23727170); Eur Cardiol. 2022 Jul 26;17:e17. (PMID: 35990402); Clin J Am Soc Nephrol. 2013 Sep;8(9):1494-501. (PMID: 23970136); Prog Biophys Mol Biol. 2008 Oct-Nov;98(2-3):340-6. (PMID: 19351522); Med Sci Sports Exerc. 2011 Jul;43(7):1334-59. (PMID: 21694556); JACC Cardiovasc Interv. 2023 Jan 23;16(2):209-218. (PMID: 36697158); Nat Rev Nephrol. 2011 Mar;7(3):145-54. (PMID: 21283136); Nat Rev Nephrol. 2018 Mar;14(3):151-164. (PMID: 29355169); Eur Heart J. 2021 Jan 1;42(1):17-96. (PMID: 32860412); J Am Soc Nephrol. 2015 Oct;26(10):2504-11. (PMID: 25733525); EBioMedicine. 2023 Mar;89:104489. (PMID: 36857859); Lancet. 2017 Mar 25;389(10075):1238-1252. (PMID: 27887750); Eur J Prev Cardiol. 2021 May 14;28(5):460-495. (PMID: 33611446); Adv Chronic Kidney Dis. 2014 Nov;21(6):480-8. (PMID: 25443573); Nephrol Dial Transplant. 2017 Apr 1;32(suppl_2):ii129-ii135. (PMID: 28206610); Eur Heart J. 2023 Jun 20;44(23):2095-2110. (PMID: 37014015); Am J Kidney Dis. 2012 Jan;59(1):126-34. (PMID: 22113127); Cardiovasc Ther. 2009 Fall;27(3):199-215. (PMID: 19689620); PLoS One. 2016 Jul 06;11(7):e0158765. (PMID: 27383068); Int Urol Nephrol. 2019 Oct;51(10):1787-1795. (PMID: 31332699); Am J Kidney Dis. 2014 Sep;64(3):383-93. (PMID: 24913219); Am J Cardiol. 2023 Apr 15;193:44-51. (PMID: 36870114); Int J Cardiol Cardiovasc Risk Prev. 2024 Sep 05;23:200331. (PMID: 39346126); Kidney Int. 2005 Aug;68(2):818-25. (PMID: 16014061); Eur J Heart Fail. 2017 Dec;19(12):1606-1614. (PMID: 28371075); High Blood Press Cardiovasc Prev. 2019 Oct;26(5):399-404. (PMID: 31463886); Semin Dial. 2011 Sep-Oct;24(5):525-32. (PMID: 21906164); Nephron. 2016;134(1):25-9. (PMID: 27050529); Circulation. 2021 Mar 16;143(11):1157-1172. (PMID: 33720773); J Nephrol. 2020 Jun;33(3):417-430. (PMID: 32065354); J Cardiopulm Rehabil Prev. 2023 Nov 1;43(6):444-452. (PMID: 36892848); Lancet. 2020 Feb 29;395(10225):709-733. (PMID: 32061315); Semin Nephrol. 2018 Nov;38(6):582-599. (PMID: 30413253); Ren Fail. 2021 Dec;43(1):1172-1179. (PMID: 34315328); Transplantation. 2016 Jul;100(7):1580-7. (PMID: 26982956); Am J Kidney Dis. 2017 Jun;69(6):837-852. (PMID: 28427790); Adv Chronic Kidney Dis. 2008 Jan;15(1):83-96. (PMID: 18155113); Nat Med. 2022 Dec;28(12):2497-2503. (PMID: 36376461); Eur Heart J. 2023 Oct 1;44(37):3627-3639. (PMID: 37622666); Eur Heart J. 2020 Jan 1;41(1):111-188. (PMID: 31504418); Clin Kidney J. 2017 Dec;10(6):783-787. (PMID: 29250324); Lancet. 2013 Jul 20;382(9888):260-72. (PMID: 23727169); Circulation. 2018 Aug 28;138(9):929-944. (PMID: 30354446); Healthcare (Basel). 2023 Mar 21;11(6):. (PMID: 36981559); J Am Soc Nephrol. 2012 Dec;23(12):1929-39. (PMID: 23100219); J Am Coll Cardiol. 2024 Jul 2;84(1):97-114. (PMID: 38925729); Lancet. 2014 May 24;383(9931):1831-43. (PMID: 24856028); J Am Coll Cardiol. 2019 Sep 10;74(10):e177-e232. (PMID: 30894318); Circulation. 2003 Oct 28;108(17):2154-69. (PMID: 14581387); J Cardiol. 2010 Sep;56(2):142-6. (PMID: 20696551); PLoS One. 2017 Jan 4;12(1):e0169400. (PMID: 28052124) |
| Contributed Indexing: | Keywords: Cardiac rehabilitation; Cardiovascular disease; Cardiovascular risk factors; Chronic kidney disease; Exercise training; Physical activity; Risk assessment |
| Entry Date(s): | Date Created: 20250428 Latest Revision: 20250429 |
| Update Code: | 20260130 |
| PubMed Central ID: | PMC12023785 |
| DOI: | 10.1016/j.ijcrp.2025.200386 |
| PMID: | 40290398 |
| Database: | MEDLINE |
Journal Article; Review